̽»¨¾«Ñ¡

Helga Westerlind

Helga Westerlind

Senior Forskningsspecialist | Docent
Telefon: +46852483354
µþ±ð²õö°ì²õ²¹»å°ù±ð²õ²õ: Maria Aspmans gata 30A, 17164 Solna
Postadress: K2 Medicin, Solna, K2 KEP Askling, 171 77 Stockholm
Del av:

Om mig

  • Docent in Epidemiology

    PhD, ̽»¨¾«Ñ¡, 2014

    MSc in Computer Science and Engineering from Royal Institute of Technology (KTH), 2009

    PhD supervision, ongoing
    Anton Öberg Sysojev (main supervisor)
    Younes Laalou (main supervisor)
    Liselotte Tidblad (co-supervisor)
    Anna-Maria Wintler (co-supervisor)
    Linnea Sjöblom (co-supervisor)

    PostDoc supervision
    Maxime Raffray, 2024-

    Students that have defended a PhD
    Weng Ian Che, 2024, co-supervisor
    Joakim Lindqvist, 2022, co-supervisor

    Students with a licentiate degree
    Daniel Berglund, 2019, Royal Institute of Technology (KTH), co-supervisor

Artiklar

  • Article: ARTHRITIS & RHEUMATOLOGY. 2025;77(9):1179-1193
    Alm LM; Westerlind H; Gehring I; Hansson M; Ghasemzadeh N; Rojas-Restrepo J; Saevarsdottir S; Sexton J; Lillegraven S; Haavardsholm E; Glintborg B; Hammer HB; Kvien TK; Hetland ML; Padyukov L; Askling J; Gronwall C
  • Article: RMD OPEN. 2025;11(3):e006035
    Che WI; Oberg Sysojev A; Zhu C; Patasova K; Smedby KE; Lundberg IE; Westerlind H; Holmqvist M
  • Article: JOURNAL OF INTERNAL MEDICINE. 2025;297(6):693-701
    Sysojev AO; Delcoigne B; Frisell T; Alfredsson L; Klareskog L; Saevarsdottir S; Boman M; Padyukov L; Askling J; Westerlind H
  • Article: RMD OPEN. 2025;11(2):e005430
    Tidblad L; Sysojev AO; Delcoigne B; Klareskog L; Alfredsson L; Askling J; Westerlind H; Saevarsdottir S
  • Article: RMD OPEN. 2025;11(1):e005111
    De Vries C; Circiumaru A; Mathsson-Alm L; Westerlind H; Dehara M; Kisten Y; Potempa B; Potempa J; Hensvold A; Lundberg K
  • Article: JOURNAL OF INTERNAL MEDICINE. 2024;296(4):336-349
    Che WI; Kuja-Halkola R; Hellgren K; Lundberg IE; Westerlind H; Baecklund F; Holmqvist M
  • Article: ARTHRITIS & RHEUMATOLOGY. 2024;76(9):1344-1352
    Sysojev AO; Alfredsson L; Klareskog L; Silberberg GN; Saevarsdottir S; Padyukov L; Magnusson PKE; Askling J; Westerlind H
  • Article: RHEUMATOLOGY. 2024;63(5):1221-1229
    Sysojev AO; Saevarsdottir S; Diaz-Gallo L-M; Silberberg GN; Alfredsson L; Klareskog L; Baecklund E; Bjorkman L; Kastbom A; Rantapaa-Dahlqvist S; Turesson C; Jonsdottir I; Stefansson K; Frisell T; Padyukov L; Askling J; Westerlind H
  • Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(3):277-287
    Pertsinidou E; Saevarsdottir S; Manivel VA; Klareskog L; Alfredsson L; Mathsson-Alm L; Hansson M; Cornillet M; Serre G; Holmdahl R; Skriner K; Jakobsson P-J; Westerlind H; Askling J; Roennelid J
  • Article: RMD OPEN. 2023;9(4):e003714
    Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
  • Article: RMD OPEN. 2023;9(3):e003027
    Westerlind H; Glintborg B; Hammer HB; Saevarsdottir S; Krogh NS; Hetland ML; Hauge E-M; Tejada IM; Sexton J; Askling J
  • Article: MULTIPLE SCLEROSIS JOURNAL. 2023;29(10):1209-1215
    Boles GS; Hillert J; Ramanujam R; Westerlind H; Olsson T; Kockum I; Manouchehrinia A
  • Article: ARTHRITIS & RHEUMATOLOGY. 2023;75(8):1445-1455
    Che WI; Baecklund F; Hellgren K; Kuja-Halkola R; Lundberg IE; Westerlind H; Holmqvist M
  • Article: RHEUMATOLOGY. 2023;62(6):2106-2112
    Westerlind H; Kastbom A; Ronnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Skriner K; Bang H; Klareskog L; Saevarsdottir S; Lundberg K; Gronwall C; Askling J
  • Article: FRONTIERS IN MEDICINE. 2023;10:1146353
    Brynedal B; Yoosuf N; Ulfarsdottir TB; Ziemek D; Maciejewski M; Folkersen L; Westerlind H; Mueller M; Sahlstrom P; Jelinsky SA; Hensvold A; Padyukov L; Pomiano NV; Catrina A; Klareskog L; Berg L
  • Article: RHEUMATOLOGY. 2023;62(3):1170-1178
    Bairkdar M; Chen EY-T; Dickman PW; Hesselstrand R; Westerlind H; Holmqvist M
  • Article: JOURNAL OF INTERNAL MEDICINE. 2023;293(2):200-211
    Che WI; Westerlind H; Lundberg IE; Hellgren K; Kuja-Halkola R; Holmqvist ME
  • Article: RMD OPEN. 2022;8(2):e002700
    Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
  • Article: FRONTIERS IN VETERINARY SCIENCE. 2022;9:976000
    Essner A; Hesbach AL; Igelstroem H; Kjellerstedt C; Svensson K; Westerlind H
  • Article: ARTHRITIS RESEARCH & THERAPY. 2022;24(1):185
    Sysojev AO; Frisell T; Delcoigne B; Saevarsdottir S; Askling J; Westerlind H
  • Visa fler

Alla övriga publikationer

  • Editorial comment: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2024;52(8):1019-1025
    Glintborg B; Hansson M; Hammer HB; Klareskog L; Saevarsdottir S; Westerlind H; Ronnelid J; Gehring I; Benson M; Esbensen BA; Hetland ML; Padyukov L; Kragstrup TW; Hauge E-M; Axnas BB; Krogh NS; Johannesson M; Askling J
  • Corrigendum: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023;63:152311
    Westerlind H; Bairkdar M; Gunnarsson K; Moshtaghi-Svensson J; Sysojev AO; Hesselstrand R; Holmqvist M
  • Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52:20-21
    Glintborg B; Hansson M; Hammer HB; Klareskog L; Saevarsdottir S; Westerlind H; Ronnelid J; Gehring I; Benson M; Esbensen BA; Hetland ML; Padyukov L; Kragstrup TW; Hauge E; Axnas BB; Krogh NS; Johannesson M; Askling J
  • Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:222-223
    Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
  • Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1297
    Di Giuseppe D; Askling J; Westerlind H
  • Letter: RHEUMATOLOGY. 2023;62(6):e204
    Westerlind H; Kastbom A; Askling J
  • Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023;41(2):415-416
    Che WI; Westerlind H; Lundberg IE; Hellgren K; Kuja-Halkola R; Holmqvist M
  • Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023;41(2):435
    Che WI; Baecklund F; Hellgren K; Kuja-Halkola R; Lundberg IE; Westerlind H; Holmqvist M
  • Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:2265-2269
    Maurits M; Abasolo Alcazar L; van den Akker E; Askling J; Barton A; Bluml S; Bohringer S; Cope A; Emery P; Eyre S; Gaddi P; Gonzalez I; Goodyear C; van der Helm-van Mil A; Hu X; Huizinga T; Isaacs JD; Jelinsky S; Johannesson M; Zapata SJ; Ke C; Klareskog L; Lendrem D; Lewis M; Liu M; Martin P; McInnes IB; Micheroli R; Morgan A; Morton F; Naamane N; Orozco G; Ospelt C; Padyukov L; Paterson C; Plant D; Porter D; Pratt A; Raychaudhuri S; Reynard L; Rodriguez-Rodriguez L; Sieghart D; Studenic P; Taylor J; Toes R; Verstappen M; Verstappen S; Westerlind H; Winkler A; Knevel R
  • Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:178
    Sysojev AO; Saevarsdottir S; Diaz-Gallo LM; Alfredsson L; Klareskog L; Frisell T; Padyukov L; Askling J; Westerlind H
  • Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):48
    Manouchehrinia A; Boles GS; Hillert J; Westerlind H; Olsson T; Kockum I
  • Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50:81-82
    Bairkdar M; Chen EYT; Dickman PW; Hesselstrand R; Westerlind H; Holmqvist M
  • Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50:78-79
    Che WI; Westerlind H; Lundberg IE; Hellgren K; Kujahalkola R; Holmqvist M
  • Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2021;51:256
    Che WI; Baecklund F; Hellgren K; Halkola RK; Lundberg IE; Westerlind H; Holmqvist M
  • Review: RHEUMATOLOGY. 2021;60(7):3121-3133
    Bairkdar M; Rossides M; Westerlind H; Hesselstrand R; Arkema EV; Holmqvist M
  • Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2021;80:1059-1060
    Westerlind H; Palmqvist I; Saevarsdottir S; Alfredsson L; Klareskog L; Di Giuseppe D
  • Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:271-272
    Tidblad L; Westerlind H; Askling J; Saevarsdottir S
  • Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:614
    Lehtonen T; Akerstedr T; Lyne L; Klareskog L; Saevarsdottir S; Alfredsson L; Westerlind H
  • Letter: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(5):e50
    Westerlind H; Holmqvist M; Ljung L; Frisell T; Askling J
  • Corrigendum: AMERICAN JOURNAL OF HUMAN GENETICS. 2019;105(4):880
    Terao C; Brynedal B; Chen Z; Jiang X; Westerlind H; Hansson M; Jakobsson P-J; Lundberg K; Skriner K; Serre G; Ronnelid J; Mathsson-Alm L; Brink M; Dahlqvist SR; Padyukov L; Gregersen PK; Barton A; Alfredsson L; Klareskog L; Raychaudhuri S
  • Visa fler

Forskningsbidrag

  • Swedish Research Council
    1 January 2024 - 31 December 2026
    Purpose and aims: To enable prevention of RA, both by providing information for public health based prevention and for precision prevention directed towards individuals at high risk for RA, and to improve outcomes for people who develop RA despite efforts towards prevention.More specific aims are to:better understand the role of environmental, genetic and immune determinants behind development of RAdevelop better diagnostic and surveillance tools to enable identification of individuals at high risk for RA (pre-RA)obtain new understanding of determinants and mechanisms for the protection against arthritis that is observed in some pre-RA individualsdevelop and evaluate digital tools that can provide patients and health care with information and capacity to test and implement precision prevention and early precision-based therapies for RA.Work planUse our large case-control and cohort studies to describe combinations of environment/life styles and genes that predict development vs protection of RAUse insights from (1) to determine which biomarkers that predict onset vs protection of RAUse novel digital tools to extend prospective cohorts of individuals at risk for RA, where prediction tools can be validated and mechanisms behind protection investigatedDevelop systems where precision prevention strategies can be tested and implemented.The long term clinical significance should be a shift in the care of RA from the present care of established disease to personalized prevention.
  • Swedish Research Council
    1 January 2023 - 31 December 2025
    Sarcoidosis is an inflammatory disease in which granulomas form in any part of the body, most often affecting the lungs and lymph nodes. The disease varies among patients in terms of onset, severity and prognosis. A major obstacle in identifying causes of sarcoidosis is the inability to distinguish between different groups of patients. Inflammatory biomarker levels in combination with genetics can be used to better characterize and treat patients.My goal is to identify subgroups of sarcoidosis patients using genetic and proteomic data and determine whether these are associated with sarcoidosis prognosis. I will achieve this goal by collecting proteogenomic data from several sources of cases and controls. First, I will examine the relationship between genetics and inflammatory proteins in sarcoidosis patients. Then I will investigate whether there are clusters of patients with similar characteristics (endotypes) using a data-driven approach. To determine whether these subgroups are clinically meaningful, we will examine whether the risk of poor prognosis is different between the endotypes.The proposed project will be the first of its kind and will reveal important mechanisms of sarcoidosis pathogenesis. The use of genetics and proteomics from pre-clinical and newly diagnosed patients will be used to set the foundation for developing non-invasive biomarkers for diagnosis and endotype-specific treatment of sarcoidosis.
  • Swedish Research Council
    1 January 2021 - 31 December 2023

´¡²Ô²õ³Ùä±ô±ô²Ô¾±²Ô²µ²¹°ù

  • Senior Forskningsspecialist, Medicin, Solna, ̽»¨¾«Ñ¡, 2022-

Examina och utbildning

  • Docent, Epidemiologi, ̽»¨¾«Ñ¡, 2022
  • Medicine Doktorsexamen, Institutionen för klinisk neurovetenskap, ̽»¨¾«Ñ¡, 2014

Nyheter från KI

Kalenderhändelser från KI